Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial.

Jakubowicz D, Landau Z, Tsameret S, Wainstein J, Raz I, Ahren B, Chapnik N, Barnea M, Ganz T, Menaged M, Mor N, Bar-Dayan Y, Froy O.

Diabetes Care. 2019 Dec;42(12):2171-2180. doi: 10.2337/dc19-1142. Epub 2019 Sep 23.

PMID:
31548244
2.

Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.

Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, Iqbal N, Öhman P, Lopes RD, Reicher B, Holman RR, Hernandez AF, Mentz RJ.

Circulation. 2019 Nov 12;140(20):1613-1622. doi: 10.1161/CIRCULATIONAHA.119.041659. Epub 2019 Sep 23.

PMID:
31542942
3.

High-Intensity Statins Are Associated With Increased Incidence of Hypoglycemia During Hospitalization of Individuals Not Critically Ill.

Khanimov I, Segal G, Wainstein J, Boaz M, Shimonov M, Leibovitz E.

Am J Med. 2019 Nov;132(11):1305-1310. doi: 10.1016/j.amjmed.2019.04.050. Epub 2019 Jun 22.

PMID:
31233703
4.

Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.

Yaron M, Roitman E, Aharon-Hananel G, Landau Z, Ganz T, Yanuv I, Rozenberg A, Karp M, Ish-Shalom M, Singer J, Wainstein J, Raz I.

Diabetes Care. 2019 Jul;42(7):1178-1184. doi: 10.2337/dc18-0166. Epub 2019 Apr 29.

PMID:
31036546
5.

Reduction of serum albumin in non-critically ill patients during hospitalization is associated with incident hypoglycaemia.

Khanimov I, Wainstein J, Boaz M, Shimonov M, Leibovitz E.

Diabetes Metab. 2019 Apr 11. pii: S1262-3636(19)30060-6. doi: 10.1016/j.diabet.2019.03.003. [Epub ahead of print]

PMID:
30981821
6.

CT-guided thrombolytic treatment of patients with wake-up strokes.

Armon C, Wainstein J, Gour A, Levite R, Bartal A, Kriboushay A, Kenan G, Khiri F, Shevtzov E, Aroesty R, Bhonkar S, Tal S, Ilgiyaev E, Blatt A, Haitov Z, Bar-Hayim S, Kimiagar I.

eNeurologicalSci. 2019 Feb 5;14:91-97. doi: 10.1016/j.ensci.2019.02.002. eCollection 2019 Mar.

7.

Documented hypoglycemia is associated with poor short and long term prognosis among patients admitted to general internal medicine departments.

Leibovitz E, Khanimov I, Wainstein J, Boaz M.

Diabetes Metab Syndr. 2019 Jan - Feb;13(1):222-226. doi: 10.1016/j.dsx.2018.07.004. Epub 2018 Jul 17.

PMID:
30641701
8.

Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study.

Sharif K, Ghadir S, Jakubowicz D, Amital H, Bragazzi NL, Watad A, Wainstein J, Bar-Dayan Y.

Cardiovasc Diabetol. 2019 Jan 11;18(1):4. doi: 10.1186/s12933-019-0810-8.

9.

Hypoglycemia- simplifying the ways to predict an old problem in the general ward.

Bar-Dayan Y, Wainstein J, Schorr L, Derazne E, Schorr Y, Jakubowicz D, Wohl Y.

Eur J Intern Med. 2019 Feb;60:13-17. doi: 10.1016/j.ejim.2018.10.007. Epub 2018 Nov 28.

PMID:
30503083
10.

Association of albumin and cholesterol levels with incidence of hypoglycaemia in people admitted to general internal medicine units.

Leibovitz E, Wainstein J, Boaz M.

Diabet Med. 2018 Dec;35(12):1735-1741. doi: 10.1111/dme.13792. Epub 2018 Aug 22.

PMID:
30091149
11.

Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial.

Ludvik B, Frías JP, Tinahones FJ, Wainstein J, Jiang H, Robertson KE, García-Pérez LE, Woodward DB, Milicevic Z.

Lancet Diabetes Endocrinol. 2018 May;6(5):370-381. doi: 10.1016/S2213-8587(18)30023-8. Epub 2018 Feb 23. Erratum in: Lancet Diabetes Endocrinol. 2018 Jun;6(6):e5.

PMID:
29483060
12.

Effect of short- and long-term diabetes control on in-hospital and one year mortality rates in hospitalized patients with diabetic foot.

Feldbrin Z, Shargorodsky M, Wainstein J, Melnikov D, Zandman-Goddard G.

Eur J Intern Med. 2018 May;51:29-33. doi: 10.1016/j.ejim.2018.01.013. Epub 2018 Jan 10.

PMID:
29329893
13.

Error in Drugs Consumption Among Older Patients.

Bar-Dayan Y, Shotashvily T, Boaz M, Wainstein J.

Am J Ther. 2017 Nov/Dec;24(6):e701-e705. doi: 10.1097/MJT.0000000000000400.

PMID:
29099732
14.

High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes.

Jakubowicz D, Wainstein J, Landau Z, Ahren B, Barnea M, Bar-Dayan Y, Froy O.

J Nutr Biochem. 2017 Nov;49:1-7. doi: 10.1016/j.jnutbio.2017.07.005. Epub 2017 Jul 21.

PMID:
28863364
15.

Lifestyle intervention program benefits children with overweigh compared to children with obesity.

Landau Z, Abiri S, Lebenthal Y, Jakubowicz D, Mor N, Lerner-Geva L, Boaz M, Wainstein J, Bar-Dayan Y.

Obes Res Clin Pract. 2018 Jan - Feb;12(1):85-92. doi: 10.1016/j.orcp.2017.07.003. Epub 2017 Aug 31.

PMID:
28838814
16.

Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial.

Jakubowicz D, Wainstein J, Landau Z, Raz I, Ahren B, Chapnik N, Ganz T, Menaged M, Barnea M, Bar-Dayan Y, Froy O.

Diabetes Care. 2017 Nov;40(11):1573-1579. doi: 10.2337/dc16-2753. Epub 2017 Aug 22.

PMID:
28830875
17.

Random blood glucose screening at a public health station encouraged high risk subjects to make lifestyle changes.

Elman K, Wainstein J, Boaz M, Jakubowicz D, Bar-Dayan Y.

Int J Clin Pract. 2017 Aug;71(8). doi: 10.1111/ijcp.12984. Epub 2017 Jul 30.

PMID:
28758307
18.

Effects of Helicobacter Pylori Colonization/Infection on the Metabolic Profile of Obese Persons Undergoing Sleeve Gastrectomy Surgery for Weight Reduction.

Shimonov M, Leibou L, Davidov E, Bernadsky O, Wainstein J, Leibovitz E.

Isr Med Assoc J. 2016 Jul;18(7):401-403.

19.

Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS.

Engel SS, Suryawanshi S, Stevens SR, Josse RG, Cornel JH, Jakuboniene N, Riefflin A, Tankova T, Wainstein J, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Obes Metab. 2017 Nov;19(11):1587-1593. doi: 10.1111/dom.12983. Epub 2017 Jul 7.

PMID:
28432745
20.

Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring Device.

Ish-Shalom M, Wainstein J, Raz I, Mosenzon O.

J Diabetes Sci Technol. 2016 Nov 1;10(6):1412-1413. Print 2016 Nov. No abstract available.

21.

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS.

Cornel JH, Bakris GL, Stevens SR, Alvarsson M, Bax WA, Chuang LM, Engel SS, Lopes RD, McGuire DK, Riefflin A, Rodbard HW, Sinay I, Tankova T, Wainstein J, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2016 Dec;39(12):2304-2310. Epub 2016 Oct 14.

PMID:
27742728
22.

Pancreatic Safety of Sitagliptin in the TECOS Study.

Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group.

Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14.

23.

Prevalence of undiagnosed hyperglycaemia in patients presenting to the Department of Emergency Medicine with no known history of diabetes.

Bar-Dayan Y, Zilberman I, Boaz M, Landau Z, Glandt M, Jakubowicz D, Wainstein J.

Int J Clin Pract. 2016 Sep;70(9):771-4. doi: 10.1111/ijcp.12867. Epub 2016 Aug 16.

PMID:
27531637
24.

Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.

Ganz T, Wainstein J, Gilad S, Limor R, Boaz M, Stern N.

Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2836. Epub 2016 Oct 5.

PMID:
27393712
25.

The role of insulin pump therapy for type 2 diabetes mellitus.

Landau Z, Raz I, Wainstein J, Bar-Dayan Y, Cahn A.

Diabetes Metab Res Rev. 2017 Jan;33(1). doi: 10.1002/dmrr.2822. Epub 2016 Jun 21. Review.

PMID:
27189155
26.

Using a public health station for screening of undiagnosed dysglycemia and hypertension.

Bar-Dayan Y, Boaz M, Landau Z, Zeev F, Jakubowicz D, Wainstein J.

Prim Care Diabetes. 2016 Oct;10(5):324-8. doi: 10.1016/j.pcd.2016.02.001. Epub 2016 Mar 8.

PMID:
26968251
27.

Purslane Extract and Glucose Homeostasis in Adults with Type 2 Diabetes: A Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety.

Wainstein J, Landau Z, Bar Dayan Y, Jakubowicz D, Grothe T, Perrinjaquet-Moccetti T, Boaz M.

J Med Food. 2016 Feb;19(2):133-40. doi: 10.1089/jmf.2015.0090.

PMID:
26854844
28.

Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2Goal(SM) concept.

Cohen O, Agabria Z, Lysyy L, Ianovitsky Y, Nguyen X, Fung M, Lee S, Wainstein J.

J Endocrinol Invest. 2016 Jun;39(6):627-33. doi: 10.1007/s40618-015-0407-3. Epub 2016 Jan 8.

29.

Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.

Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O.

Diabetes Care. 2015 Oct;38(10):1820-6. doi: 10.2337/dc15-0761. Epub 2015 Jul 28.

PMID:
26220945
30.

Hyperglycaemia in patients with no history of diabetes presenting to Internal Medicine Departments.

Bar-Dayan Y, Beer I, Boaz M, Landau Z, Jakubowicz D, Wainstein J.

Int J Clin Pract. 2015 Nov;69(11):1289-95. doi: 10.1111/ijcp.12690. Epub 2015 Jul 14.

PMID:
26178790
31.

High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: a randomised clinical trial.

Jakubowicz D, Wainstein J, Ahrén B, Bar-Dayan Y, Landau Z, Rabinovitz HR, Froy O.

Diabetologia. 2015 May;58(5):912-9. doi: 10.1007/s00125-015-3524-9. Epub 2015 Mar 1.

PMID:
25724569
32.

Disrupting mitochondrial-nuclear coevolution affects OXPHOS complex I integrity and impacts human health.

Gershoni M, Levin L, Ovadia O, Toiw Y, Shani N, Dadon S, Barzilai N, Bergman A, Atzmon G, Wainstein J, Tsur A, Nijtmans L, Glaser B, Mishmar D.

Genome Biol Evol. 2014 Sep 22;6(10):2665-80. doi: 10.1093/gbe/evu208.

33.

Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial.

Jakubowicz D, Froy O, Ahrén B, Boaz M, Landau Z, Bar-Dayan Y, Ganz T, Barnea M, Wainstein J.

Diabetologia. 2014 Sep;57(9):1807-11. doi: 10.1007/s00125-014-3305-x. Epub 2014 Jul 10.

PMID:
25005331
34.

Treatment of recent-onset type 1 diabetic patients with DiaPep277: results of a double-blind, placebo-controlled, randomized phase 3 trial.

Raz I, Ziegler AG, Linn T, Schernthaner G, Bonnici F, Distiller LA, Giordano C, Giorgino F, de Vries L, Mauricio D, Procházka V, Wainstein J, Elias D, Avron A, Tamir M, Eren R, Peled D, Dagan S, Cohen IR, Pozzilli P; DIA-AID 1 Writing Group.

Diabetes Care. 2014;37(5):1392-400. doi: 10.2337/dc13-1391. Retraction in: Diabetes Care. 2015 Jan;38(1):178.

PMID:
24757230
35.

[The dual role of the physician: medicine and research].

Freud-Silverberg M, Ben David L, Rabin S, Wainstein J.

Harefuah. 2014 Feb;153(2):101-3, 126, 125. Review. Hebrew.

PMID:
24716428
36.

Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device.

Landau Z, Klonoff D, Nayberg I, Feldman D, Levit SB, Lender D, Mosenzon O, Raz I, Wainstein J.

Diabetes Metab Res Rev. 2014 Nov;30(8):686-92. doi: 10.1002/dmrr.2536.

PMID:
24610683
37.

Gender aspects suggestive of gastroparesis in patients with diabetes mellitus: a cross-sectional survey.

Dickman R, Wainstein J, Glezerman M, Niv Y, Boaz M.

BMC Gastroenterol. 2014 Feb 19;14:34. doi: 10.1186/1471-230X-14-34.

38.

Atopic dermatitis in Israeli adolescents - a large retrospective cohort study.

Wohl Y, Wainstein J, Bar-Dayan Y.

Acta Derm Venereol. 2014 Nov;94(6):695-8. doi: 10.2340/00015555-1819.

39.

Inpatient hyperglycaemia improvement quality program.

Bar-Dayan Y, Landau Z, Boaz M, Chaimy T, Matas Z, Wainstein J.

Int J Clin Pract. 2014 Apr;68(4):495-502. doi: 10.1111/ijcp.12344. Epub 2014 Jan 22.

PMID:
24447307
40.

Opinion and knowledge among hospital medical staff regarding diagnosis of diabetes and proper usage of a specific test tube for glucose analysis.

Bar-Dayan Y, Bogaiov A, Boaz M, Landau Z, Wainstein J.

Int J Clin Pract. 2014 Feb;68(2):278-82. doi: 10.1111/ijcp.12314. Epub 2013 Dec 22.

PMID:
24373068
41.

Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes.

Landau Z, Rachmiel M, Pinhas-Hamiel O, Boaz M, Bar-Dayan Y, Wainstein J, Tauman R.

Acta Diabetol. 2014;51(3):499-503. doi: 10.1007/s00592-013-0545-z. Epub 2013 Dec 27.

PMID:
24370924
42.

Association of the M3151 variant in the transient receptor potential vanilloid receptor-1 (TRPV1) gene with type 1 diabetes in an Ashkenazi Jewish population.

Sadeh M, Glazer B, Landau Z, Wainstein J, Bezaleli T, Dabby R, Hanukoglu A, Boaz M, Leshinsky-Silver E.

Isr Med Assoc J. 2013 Sep;15(9):477-80.

43.

Big breakfast rich in protein and fat improves glycemic control in type 2 diabetics.

Rabinovitz HR, Boaz M, Ganz T, Jakubowicz D, Matas Z, Madar Z, Wainstein J.

Obesity (Silver Spring). 2014 May;22(5):E46-54. doi: 10.1002/oby.20654. Epub 2013 Dec 6.

44.

The use of a CoolSense device to lower pain sensation during finger pricking while measuring blood glucose in diabetes patients--a randomized placebo.

Wainstein J, Chimin G, Landau Z, Boaz M, Jakubowicz D, Goddard G, Bar-Dayan Y.

Diabetes Technol Ther. 2013 Aug;15(8):688-94. doi: 10.1089/dia.2012.0278. Epub 2013 Jul 17.

PMID:
23863047
45.

Institutional point-of-care glucometer identifies population trends in blood glucose associated with war.

Boaz M, Matas Z, Chaimy T, Landau Z, Bar Dayan Y, Berlovitz Y, Wainstein J.

Diabetes Technol Ther. 2013 Nov;15(11):964-7. doi: 10.1089/dia.2013.0035. Epub 2013 Jul 16.

PMID:
23859652
46.

Evaluation of an intra-institutional diabetes disease management program for the glycemic control of elderly long-term care diabetic patients.

Lubart E, Segal R, Wainstein J, Marinov G, Yarovoy A, Leibovitz A.

Geriatr Gerontol Int. 2014 Apr;14(2):341-5. doi: 10.1111/ggi.12104. Epub 2013 Jun 10.

PMID:
23750823
47.

Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome.

Jakubowicz D, Barnea M, Wainstein J, Froy O.

Clin Sci (Lond). 2013 Nov;125(9):423-32. doi: 10.1042/CS20130071.

PMID:
23688334
48.

High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women.

Jakubowicz D, Barnea M, Wainstein J, Froy O.

Obesity (Silver Spring). 2013 Dec;21(12):2504-12. doi: 10.1002/oby.20460. Epub 2013 Jul 2.

49.

Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus.

Dickman R, Kislov J, Boaz M, Ron Y, Beniashvili Z, Raz I, Baigel I, Niv Y, Wainstein J.

J Diabetes Complications. 2013 Jul-Aug;27(4):376-9. doi: 10.1016/j.jdiacomp.2013.02.004. Epub 2013 Mar 16.

PMID:
23507560
50.

Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes.

Tamir O, Wainstein J, Raz I, Shemer J, Heymann A.

Rev Diabet Stud. 2012 Spring;9(1):46-54. doi: 10.1900/RDS.2012.9.46. Epub 2012 May 10.

Supplemental Content

Loading ...
Support Center